In type 2 diabetes, the effectiveness and side effects of GLP-1 RAs vary.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 38710089.
- Also identified by DOI 10.7326/J24-0028.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Yao H, Zhang A, Li D, et al. <b>Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis.</b> BMJ. 2024;384:e076410. 38286487.
Medical subject headings
- Diabetes Mellitus, Type 2
- Glucagon-Like Peptide-1 Receptor Agonists
- Hypoglycemic Agents